Serge Saxonov - 12 Sep 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Executive Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol: TXG
Transactions as of: 12 Sep 2022
Net transactions value: +$13,800
Form type: 4
Filing time: 14 Sep 2022, 17:55:13 UTC
Previous filing: 25 Aug 2022
Next filing: 16 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$13,800	+11,500	+1.2%	$1.20^*	977,602	12 Sep 2022	Direct
holding	TXG	Class A Common Stock						2,487	12 Sep 2022	See footnote	F1
holding	TXG	Class A Common Stock						89,960	12 Sep 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-11,500	-22%	$0.000000	41,035	12 Sep 2022	Class A Common Stock	11,500	$1.20	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2	The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F3	This option, originally for 300,000 shares, of which 258,965 have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.